Skip to Main Content
Contribute Try STAT+ Today

As the U.S. midterm elections draw closer, yet another poll finds that Americans remain very concerned about prescription drug pricing and are unhappy with how Washington is trying to resolve the issue.

Specifically, 77 percent regard drug costs as unreasonable and 65 percent report they are extremely or very concerned about prices, according to a poll of 1,022 adults Americans that was conducted last month by a pair of nonprofit research groups, the West Health Institute and NORC at the University of Chicago.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.